Posted by Michael Wonder on 09 Dec 2024
Cladribine for the treatment of patients with relapsing multiple sclerosis
6 December 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use of cladribine in the NHS in England.
For the time being, cladribine is not recommended for the treatment of adults with relapsing forms of multiple sclerosis with active disease, as defined by clinical and imaging features.
